Clinical trials

9

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Social Prescribing for a Mindful Lifestyle

The goal of this clinical trial is to evaluate the effectiveness of an 8-week mindfulness lifestyle social prescribing program in community-dwelling older adults aged 55 and older. The main questions it aims to answer are: To establish a mindfulness lifestyle social prescribing model applied to the psychological and social health promotion of middle-aged and older populations. To evaluate the effectiveness of the intervention on improving depressive symptoms, loneliness, and quality of life in this population. Participants will receive an 8-week group intervention program, with each weekly session lasting approximately 3 hours. The structured curriculum integrates mindfulness awareness, body scanning, mindfulness stretching, breathing training, healthy dietary education, and art practices (such as herbal therapy and leaf printing). Researchers will collect and evaluate data from pre- and post-intervention assessments to measure changes in depressive symptoms, loneliness risk, and overall quality of life.

Participants needed: 50
Trial details
Age: 55+Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Jun 25, 2026Locations: 1
Eligibility criteria

People aged 55 years or older. [+2]

People that are unable to cooperate with the project or follow-up. [+4]

Status: Recruiting

Moxibustion for Nocturia

Nocturia, the interruption of sleep due to nighttime voiding, severely compromises quality of life, emotional health, and overall well-being when occurring twice or more per night. Given that some patients experience inadequate responses to conventional Western therapies or harbor concerns about the long-term side effects of pharmaceuticals, many are turning to Traditional Chinese Medicine (TCM) for alternative solutions. This study utilized a randomized clinical trial design to investigate the efficacy and safety of acupoint moxibustion for nocturia.

Participants needed: 100
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: May 20, 2026Locations: 1
Eligibility criteria

Patients aged 40 years or older. [+1]

Active urinary tract infection (UTI). [+5]

Status: Recruiting

Epidural Electrical Stimulation for Spinal Cord Injury Patients and Corticospinal Motor Circuit Improvement

The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.

Participants needed: 20
Trial details
Age: 20-70Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Sep 19, 2025Locations: 1
Eligibility criteria

SCI ASIA: A, B, C,D [+7]

Have significant cognitive impairment (MMSE<24). [+7]

Status: Recruiting

Epidural Electrical Stimulation for Stroke Patients - Improve Motor and Sensory Function and Alleviate Pain

This study aims to verify whether epidural electrical stimulation (EES) of the cervical spinal cord can activate muscles of the upper limbs in people with hemiplegia following a stroke.

Participants needed: 20
Trial details
Age: 20-70Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Sep 19, 2025Locations: 1
Eligibility criteria

Between 20 and 70 years of age [+6]

Pregnancy or breast feeding. [+8]

Status: Recruiting

Spinal Cord Stimulation for Spinal Cord Injury Patients - Regain Walk and Alleviate Pain

The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.

Participants needed: 12
Trial details
Age: 20-70Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Sep 19, 2025Locations: 1
Eligibility criteria

SCI ASIA: A, B, C,D [+7]

Have significant cognitive impairment (MMSE<24). [+7]

Status: Recruiting

The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

Lung cancer is currently the leading cause of cancer-related mortality worldwide, and the dominant histopathology is non-small cell lung cancer (NSCLC). Although many new targeted and immunomodulation therapies have emerged, not all patients are responsive to novel therapeutics. A more reliable and accurate risk stratification model to predict the treatment response and survival outcomes are still lacking. The 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) derived radiomics can be used to interrogate tumor biologies such as glycolytic activity and heterogeneity. It can, therefore, be used to predict treatment response and survival outcomes. Cancer genomics derived from gene sequencing can evaluate cancer's genetic alterations. It can be used to feature the genotype of the tumor. However, both tools have drawbacks; combining these two modalities may enable a more robust predictive model for more precise clinical decisions. During the investigator's former study project, the investigators published four Science Citation Index journal papers using the investigators' research results, which found that 18F-FDG PET radiomics can independently predict regional lymph node metastasis in NSCLC and cancer survival by stage. The preliminary findings of the investigator's former research project also disclosed an association between 18F-FDG PET-derived molecular radiomics with genomic heterogeneity and mutation of specific glucose metabolic genes. This time, the investigators plan to include deep radiomics in addition to traditional handcrafted radiomics. The investigators aim to investigate the radiogenomic patterns in different driver gene mutation statuses and clinical scenarios. Finally, the investigators seek to use radiogenomics as a prognostic stratification tool in patients with NSCLC.

Participants needed: 120
Trial details
Age: 20+Biological sex: AllType: ObservationalSponsor: Buddhist Tzu Chi General HospitalUpdated: Sep 19, 2025Locations: 1
Eligibility criteria

Age at least 20-years [+2]

Coexistence of non-aerodigestive tract cancer. [+2]

Status: Not yet recruiting

The Effects of a Dialysis-Specific Formula Rich in Branched-Chain Amino Acids, Omega-3, and Dietary Fiber on Nutritional Status

The aim of this study is to evaluate the effects of a specialized oral nutritional supplement (SF) enriched with BCAAs, omega-3 fatty acids, and dietary fiber on improving the nutritional status of dialysis patients with mild to moderate malnutrition, and thereby alleviating fatigue and enhancing quality of life. We will assess various aspects of protein-energy wasting (PEW), as well as changes in the Malnutrition Inflammation Score (MIS), Geriatric Nutritional Risk Index (GNRI), fatigue, appetite, serum BCAA levels, uremic toxins, and gut microbiota composition.

Participants needed: 100
Trial details
Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Jul 11, 2025
Eligibility criteria

Patients with ESRD who have been receiving dialysis for more than three months [+2]

Serum albumin (Alb) < 3.0 g/dL [+4]

Status: Not yet recruiting

Huandao Conditioning Application for Allergic Rhinitis Treatment

The goal of this clinical trial is to learn if the Huandao Conditioning Application works to treat allergic rhinitis in adults. It will also learn about the safety of this application. The main questions it aims to answer are: Does the Huandao Conditioning Application improve allergic rhinitis symptoms as measured by the Rhinitis Control Assessment Test (RCAT) and nasal airway resistance tests? What medical problems do participants have when using the Huandao Conditioning Application? Researchers will compare the therapeutic version of the application to a placebo version (a look-alike application that contains no therapeutic effect) to see if the Huandao Conditioning Application works to treat allergic rhinitis. Participants will: Use either the therapeutic or placebo version of the application daily for 1 week in Phase 1 Take a 2-week break with no application use Use the opposite version of the application daily for 1 week in Phase 2 Visit the clinic at the beginning and end of each phase for checkups and tests Complete symptom assessment questionnaires before each application use and 1-2 hours after use Be monitored for any adverse reactions throughout the study period

Participants needed: 95
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Feb 13, 2025
Eligibility criteria

Age ≥ 18 years [+3]

Recent diagnosis, active treatment, or recurrence risk of head/neck cancer [+2]

Status: Recruiting

Effectiveness of Integrated Care Combined Nutrition and Lifestyle Counselling in Frail Older Patients With Diabetes

The goal of this clinical trial is to evaluate the effectiveness of innovative integrated care in pre-frail or frail patients with diabetes over 65 years old. The main questions it aims to answer are: * To establish innovative integrated care for frail elderly patients with diabetes combined with nutrition and lifestyle guidance. * To evaluate the effectiveness of the intervention compared with general outpatient care. Participants will receive 12 weeks of structured care including specialist care, integrated assessment, group health education, one-on-one nutrition and lifestyle guidance, online and face-to-face support group, and case management. Researchers will compare general outpatient care to see its effects on frailty, physical function, and blood sugar control.

Participants needed: 100
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Buddhist Tzu Chi General HospitalUpdated: Aug 7, 2024Locations: 1
Eligibility criteria

People aged 65 years or older. [+3]

People that are unable to cooperate with or accept intervention or follow-up. [+8]